What’s News in Markets: Amgen’s Prognosis, Quantum Boost, iPhone Makeover
From WSJ Your Money Briefing · · 5 min
This plays from the publisher's own server. We do not host a copy.
Not rated yet
Description
Why did a failed Novartis drug trial tank Amgen’s shares? And how is taxpayer money funding quantum-computing companies? Plus, will people pay $2,000 for a foldable iPhone? Host Imani Moise discusses the biggest stock moves of the week and the news that drove them.
Sign up for the WSJ's free Markets A.M. newsletter (https://www.wsj.com/newsletters/markets-am?mod=WSJ_YMBPOD).
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com (https://pcm.adswizz.com) for information about our collection and use of personal data for advertising.